Clinical Trials for Oligodendroglioma

Find clinical trials for oligodendroglioma. Discover research opportunities and treatment options in your area.

19 Active Trials Found

Showing 19 trials on this page

Page 1 of 1

Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma

NCT ID: NCT07031765

This clinical trial, called Peds CHAMP1ON, is studying a new treatment approach for children and young adults who have certain types of high-grade brain tumors that have come back or are not respon...

Not yet recruiting

Phase: PHASE1 Type: interventional

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

NCT ID: NCT04623931

This clinical trial is studying a combination of chemotherapy and radiation therapy to treat certain types of brain tumors known as IDH wildtype gliomas, which include conditions like anaplastic as...

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma

NCT ID: NCT05484622

This clinical trial is studying a new treatment approach for patients with a specific type of brain tumor called astrocytoma, which is caused by a genetic mutation known as IDH-1. The trial is test...

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, Ann Arbor, Michigan, United States +27 more

FearLess in NeuroOncology

NCT ID: NCT06989086

The FearLess in NeuroOncology trial is a study looking at how to best support patients with primary malignant brain tumors, like glioblastoma and astrocytoma, and their caregivers. The main goal is...

Not yet recruiting

Type: observational Locations: Richmond, Virginia, United States

HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)

NCT ID: NCT06930846

The HOBSCOTCH-CA trial is studying a program designed to help improve the quality of life and cognitive abilities of people who have survived brain cancer or brain tumors. This includes various typ...

Not yet recruiting

Phase: NA Type: interventional

A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery

NCT ID: NCT04702581

This clinical trial is studying how delaying radiotherapy (a type of cancer treatment using high-energy rays) for patients with low-grade oligodendrogliomas (a type of brain tumor) affects their co...

Phase: PHASE3 Type: interventional Locations: Rouen, , France, Caen, , France +24 more

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

NCT ID: NCT05956821

This clinical trial is exploring a new treatment for young patients under 22 years old who have certain types of brain tumors, specifically those that have come back or haven’t responded to previou...

Phase: PHASE1 Type: interventional Locations: Miami, Florida, United States

Study of Olutasidenib and Temozolomide in HGG

NCT ID: NCT06161974

This clinical trial is studying the effectiveness of a new treatment combining two drugs, olutasidenib and temozolomide, for young patients recently diagnosed with high-grade glioma (HGG) that has ...

Phase: PHASE2 Type: interventional Locations: Randwick, New South Wales, Australia, Cincinnati, Ohio, United States +18 more

All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma

NCT ID: NCT05345002

This clinical trial is studying the effects of a combination treatment using All-Trans Retinoic Acid (ATRA) and a drug called Retifanlimab on patients with recurrent IDH-mutant glioma, a type of br...

Phase: PHASE2 Type: interventional Locations: Philadelphia, Pennsylvania, United States

PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas

NCT ID: NCT05190172

The PRO-GLIO trial is studying the use of two different types of radiation therapy—proton therapy and photon therapy—for patients with certain types of brain tumors called IDH-mutated diffuse gliom...

Phase: NA Type: interventional Locations: Oslo, , Norway

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

NCT ID: NCT04541082

This clinical trial is investigating a new medication called ONC206, taken by mouth, for patients with certain types of brain tumors that have come back after treatment. The main goal of the study ...

Phase: PHASE1 Type: interventional Locations: Bethesda, Maryland, United States

A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).

NCT ID: NCT05331521

This clinical trial, called NOA-18/IMPROVE CODEL, is investigating new treatment options for adults with newly diagnosed brain tumors known as oligodendrogliomas. The goal is to improve both surviv...

Phase: PHASE3 Type: interventional Locations: Heidelberg, , Germany, Heidelberg, Baden Württemberg, Germany +18 more

Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology

NCT ID: NCT04648462

The ProTRAIT clinical trial is studying the use of proton therapy for treating certain types of brain tumors, including astrocytomas and ependymomas. Proton therapy is a special kind of radiation t...

Type: observational Locations: Maastricht, Limburg, Netherlands, Delft, Zuid Holland, Netherlands +1 more

Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas

NCT ID: NCT01849952

This clinical trial is studying a specific molecule called microRNA-10b (miRNA-10b) to see how it behaves in patients with different types of brain tumors, including glioblastomas and other gliomas...

Type: observational Locations: Boston, Massachusetts, United States, Lebanon, New Hampshire, United States +2 more

A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2

NCT ID: NCT03152318

This clinical trial is studying a new treatment for patients with recurrent malignant glioma, a type of brain cancer. The treatment involves an investigational drug called rQNestin34.5v.2, which is...

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, New York, New York, United States +4 more

Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas

NCT ID: NCT06241391

This clinical trial is studying a new imaging technique called Ga-68 Prostate Specific Membrane Antigen (PSMA) PET/CT to see how well it can detect recurrent gliomas, which are types of brain tumor...

Not yet recruiting

Phase: NA Type: interventional Locations: Bhubaneswar, Odisha, India

Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)

NCT ID: NCT06038760

The PEAR-GLIO clinical trial is studying a new tool developed by Pear Bio that uses a 3D model of a patient's brain tumor to see how it responds to different cancer treatments. This trial is specif...

Type: observational Locations: London, , United Kingdom

Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Oligodendroglioma

NCT ID: NCT05512351

This clinical trial is studying a combination treatment of two medications, sintilimab and low-dose bevacizumab, for adults with a specific type of brain tumor called oligodendroglioma that has ret...

Phase: PHASE2 Type: interventional Locations: Zhengzhou, Henan, China

Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma

NCT ID: NCT01649830

This clinical trial is studying the effectiveness of a treatment called temozolomide (TMZ) given after radiation therapy for patients with low-grade gliomas (LGG), which are a type of brain tumor. ...

Phase: PHASE3 Type: interventional Locations: Guangzhou, Guangdong, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions